ClinConnect ClinConnect Logo
Search / Trial NCT05221060

Urdu Version of Kujala Questionnaire: A Reliability and Validity Study

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Feb 1, 2022

Trial Information

Current as of May 28, 2025

Completed

Keywords

Kujala Questionnaire Patello Femoral Pain Syndrome Anterior Knee Pain Validity Functional Limitations Reliability

ClinConnect Summary

The original English version of Kujala Questionnaire will be translated and culturally adapted as per previous recommendation. In patients with anterior knee pain or patella femoral knee pain, Kujala Questionnaire-Urdu will be distributed among hundred participants choose a convenience sampling technique based on pre-defined inclusion and exclusion criteria. To test reliability of inter/intra observer of ultimate final Urdu Version of Kujala, 36-Item Short Form Health Survey questionnaire, Lysholm Knee Scoring Scale and 2000 International Knee Documentation Committee Subjective Knee Evaluat...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Both genders
  • 2. Ages range from 18-40 years
  • 3. They have clinically diagnosed with patello femoral pain syndrome (the diagnosis was established by a positive patellar grind test and pain on touch sensation, found in medial and lateral patellar facets)
  • 4. Participants who acquire 40 to 80 score on Kujala patellofemoral questionnaire before the treatment start
  • 5. Patients willing to participate.
  • Exclusion Criteria:
  • 1. Participants of the study who has gone through any treatment protocol curative measure for patellofemoral pain syndrome during the last 3 months.
  • 2. Any indication or medical record of lower extremity fracture or surgical procedure
  • 3. History of certain chronic disease e.g. Diabetes Mellitus
  • 4. Participants unable to understand Urdu Version of Kujala

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Faisalabad, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Muhammad Kashif

Study Director

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials